MoneyWorks4Me

Marksans Pharma informs about compliances-certificate

11 Oct 2023 Evaluate
Marksans Pharma has informed that it enclosed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2023 received from Bigshare Services, Registrar and Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..